Literature DB >> 31987673

Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.

Shengming Xu1, Bao Sun2, Rong Zhou1, Chaoji Shi1, Yong Han1, Jiayi Li1, Jingjing Sun2, Zhen Tian2, Zhiyuan Zhang3, Jiang Li4.   

Abstract

OBJECTIVES: The aim of this study was to characterize the clinicopathologic features of patients with oropharyngeal squamous cell carcinoma (OPSCC) in an eastern Chinese population and to evaluate the diagnostic validity of p16 immunochemistry (IHC) for HPV status detection in OPSCC. STUDY
DESIGN: A total of 257 paraffin-embedded primary OPSCC specimens were collected from 2014 to 2019. HPV RNA in situ hybridization (ISH) was conducted as the gold standard for the detection of transcriptionally active HPV status and HPV DNA polymerase chain reaction (PCR), p16 IHC, next-generation-sequencing for TP53 exons were also performed and the results analyzed for comparison.
RESULTS: The overall HPV infection rate was 18.29% (47 of 257) and the TP53 mutation frequency was 13.16% (5 of 38) and 94.74% (18 of 19) in patients with HPV-positive and HPV-negative OPSCC, respectively (P < .001). p16 IHC had the worst diagnostic ability and prognosis predictive value (disease-specific survival [DSS]; P = .405) compared with HPV DNA PCR as well as combination of p16 IHC and HPV DNA PCR. However, the diagnostic ability of p16 IHC was better in OPSCC without tobacco or alcohol exposure.
CONCLUSIONS: Solitary p16 IHC is insufficient for HPV status detection in patients with OPSCC with tobacco and/or alcohol exposure but performs better in those without exposure, and additional HPV DNA specific testing may be necessary for accurate HPV status determination.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2019        PMID: 31987673     DOI: 10.1016/j.oooo.2019.11.008

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  6 in total

1.  Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.

Authors:  Tingting Xu; Chunying Shen; Ye Wei; Chaosu Hu; Yu Wang; Jun Xiang; Guo-Hua Sun; Fengtao Su; Qifeng Wang; Xueguan Lu
Journal:  Cancer Med       Date:  2020-07-27       Impact factor: 4.452

2.  Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.

Authors:  Zirong Huo; Shuiting Fu; Chunyue Ma; Surui Sheng
Journal:  BMC Cancer       Date:  2022-05-12       Impact factor: 4.638

3.  Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients.

Authors:  Haoyue Xu; Kai Song; Lizheng Qin; Yi Qu; Qifang Niu; Bo Li; Zhengxue Han
Journal:  Hum Vaccin Immunother       Date:  2021-03-09       Impact factor: 3.452

4.  Diagnostic Accuracy of HPV Detection in Patients with Oropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-Analysis.

Authors:  Kathrine Kronberg Jakobsen; Amanda-Louise Fenger Carlander; Simone Kloch Bendtsen; Martin Garset-Zamani; Charlotte Duch Lynggaard; Christian Grønhøj; Christian von Buchwald
Journal:  Viruses       Date:  2021-08-26       Impact factor: 5.048

5.  Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report.

Authors:  Mateja Sladič; Pepita Taneska; Branko Cvjetičanin; Mojca Velikonja; Vladimir Smrkolj; Špela Smrkolj
Journal:  Medicina (Kaunas)       Date:  2022-02-23       Impact factor: 2.430

Review 6.  Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.

Authors:  Haoru Dong; Xinhua Shu; Qiang Xu; Chen Zhu; Andreas M Kaufmann; Zhi-Ming Zheng; Andreas E Albers; Xu Qian
Journal:  Virol Sin       Date:  2021-06-21       Impact factor: 4.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.